Janet Schlechte

9.1k total citations · 3 hit papers
97 papers, 6.4k citations indexed

About

Janet Schlechte is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Neurology. According to data from OpenAlex, Janet Schlechte has authored 97 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Endocrinology, Diabetes and Metabolism, 21 papers in Surgery and 8 papers in Neurology. Recurrent topics in Janet Schlechte's work include Pituitary Gland Disorders and Treatments (42 papers), Growth Hormone and Insulin-like Growth Factors (35 papers) and Adrenal and Paraganglionic Tumors (18 papers). Janet Schlechte is often cited by papers focused on Pituitary Gland Disorders and Treatments (42 papers), Growth Hormone and Insulin-like Growth Factors (35 papers) and Adrenal and Paraganglionic Tumors (18 papers). Janet Schlechte collaborates with scholars based in United States, United Kingdom and Spain. Janet Schlechte's co-authors include David L. Kleinberg, Шломо Мелмед, John Wass, Felipe F. Casanueva, David A. Lewis, Barry M. Sherman, Andrew R. Hoffman, Víctor M. Montori, Michael W. Varner and Chadi A. Calarge and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Annals of Internal Medicine.

In The Last Decade

Janet Schlechte

94 papers receiving 6.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline

2011 1.1k citations Шломо Мелмед, Felipe F. Casanueva et al. The Journal of Clinical Endocrinology & Metabolism profile →
Guidelines for Acromegaly Management: An Update

2009 549 citations Шломо Мелмед, Annamaria Colao et al. The Journal of Clinical Endocrinology & Metabolism profile →
Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas

2006 533 citations Felipe F. Casanueva, Mark E. Molitch et al. Clinical Endocrinology profile →

Peers

Janet Schlechte

EDM

SURGE

EPIDE

PHEOH

Claus Hagen Denmark

Anne Klibanski United States

Marianne Andersen Denmark

Beverly M. K. Biller United States

Christian J. Strasburger Germany

David J. Torpy Australia

Varant Kupelian United States

John G. Kral United States

Kerstin Albertsson‐Wikland Sweden

Anton Luger Austria

Claus Hagen Denmark

Janet Schlechte

3.5k ×0.9

EDM

1.0k ×0.6

SURGE

575 ×0.7

EPIDE

627 ×0.8

PHEOH

892 ×1.8

Citations per year, relative to Janet Schlechte Janet Schlechte (= 1×) peers Claus Hagen

Countries citing papers authored by Janet Schlechte

Since Specialization

Citations

This map shows the geographic impact of Janet Schlechte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janet Schlechte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janet Schlechte more than expected).

Fields of papers citing papers by Janet Schlechte

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janet Schlechte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janet Schlechte. The network helps show where Janet Schlechte may publish in the future.

Co-authorship network of co-authors of Janet Schlechte

This figure shows the co-authorship network connecting the top 25 collaborators of Janet Schlechte. A scholar is included among the top collaborators of Janet Schlechte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janet Schlechte. Janet Schlechte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Calarge, Chadi A., James A. Mills, Ekhard E. Ziegler, & Janet Schlechte. (2017). Calcium and Vitamin D Supplementation in Boys with Risperidone-Induced Hyperprolactinemia: A Randomized, Placebo-Controlled Pilot Study. Journal of Child and Adolescent Psychopharmacology. 28(2). 145–150. 2 indexed citations

Calarge, Chadi A., Ginger E. Nicol, Janet Schlechte, & Trudy L. Burns. (2014). Cardiometabolic Outcomes in Children and Adolescents Following Discontinuation of Long-Term Risperidone Treatment. Journal of Child and Adolescent Psychopharmacology. 24(3). 120–129. 26 indexed citations

Shibli‐Rahhal, Amal & Janet Schlechte. (2011). Hyperprolactinemia and Infertility. Endocrinology and Metabolism Clinics of North America. 40(4). 837–846. 29 indexed citations

Мелмед, Шломо, Felipe F. Casanueva, Andrew R. Hoffman, et al.. (2011). Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism. 96(2). 273–288. 1124 indexed citations breakdown →

Calarge, Chadi A., Vicki L. Ellingrod, Bridget Zimmerman, Michael Bliziotes, & Janet Schlechte. (2011). Variants of the Serotonin Transporter Gene, Selective Serotonin Reuptake Inhibitors, and Bone Mineral Density in Risperidone-Treated Boys. The Journal of Clinical Psychiatry. 72(12). 1685–1690. 14 indexed citations

Мелмед, Шломо, Annamaria Colao, Ariel L. Barkan, et al.. (2009). Guidelines for Acromegaly Management: An Update. The Journal of Clinical Endocrinology & Metabolism. 94(5). 1509–1517. 549 indexed citations breakdown →

Calarge, Chadi A., Laura Ación, Samuel Kuperman, Michael Tansey, & Janet Schlechte. (2009). Weight Gain and Metabolic Abnormalities During Extended Risperidone Treatment in Children and Adolescents. Journal of Child and Adolescent Psychopharmacology. 19(2). 101–109. 91 indexed citations

Calarge, Chadi A., Vicki L. Ellingrod, Bridget Zimmerman, et al.. (2009). Leptin Gene –2548G/A variants predict risperidone-associated weight gain in children and adolescents. Psychiatric Genetics. 19(6). 320–327. 42 indexed citations

Shibli‐Rahhal, Amal & Janet Schlechte. (2008). The effects of hyperprolactinemia on bone and fat. Pituitary. 12(2). 96–104. 80 indexed citations

10.

Casanueva, Felipe F., Mark E. Molitch, Janet Schlechte, et al.. (2006). Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas. Clinical Endocrinology. 65(2). 265–273. 533 indexed citations breakdown →

11.

Shields, Richard K., et al.. (2005). Bone Mineral Density After Spinal Cord Injury: A Reliable Method for Knee Measurement. Archives of Physical Medicine and Rehabilitation. 86(10). 1969–1973. 57 indexed citations

12.

Goldner, Whitney & Janet Schlechte. (2004). What's the best approach to hyperprolactinemia?. Contemporary ob/gyn. 49(5). 49–54.

13.

Schlechte, Janet. (2003). Prolactinoma. New England Journal of Medicine. 349(21). 2035–2041. 156 indexed citations

14.

Walker, Sara E., et al.. (1998). Effects of Prolactin in Stimulating Disease Activity in Systemic Lupus Erythematosus^a. Annals of the New York Academy of Sciences. 840(1). 762–772. 51 indexed citations

15.

Schlechte, Janet. (1995). Clinical impact of hyperprolactinaemia. Baillière s Clinical Endocrinology and Metabolism. 9(2). 359–366. 20 indexed citations

16.

Schlechte, Janet, et al.. (1993). Contemporary Therapy of Prolactin-Secreting Adenomas. The American Journal of the Medical Sciences. 306(6). 395–397. 9 indexed citations

17.

Schlechte, Janet, et al.. (1990). Potentiation of glucocorticoid-induced cytolysis in sensitive human leukemic cells by an inhibitor of ADP-ribosylation. Leukemia Research. 14(10). 909–914. 2 indexed citations

18.

Schlechte, Janet, et al.. (1989). The Natural History of Untreated Hyperprolactinemia: A Prospective Analysis*. The Journal of Clinical Endocrinology & Metabolism. 68(2). 412–418. 154 indexed citations

19.

Schlechte, Janet & David Hamilton. (1987). THE EFFECT OF GLUCOCORTICOIDS ON CORTICOSTEROID BINDING GLOBULIN. Clinical Endocrinology. 27(2). 197–203. 64 indexed citations

20.

Schlechte, Janet, Barry M. Sherman, & Bruce Pfohl. (1986). A Comparison of Adrenal Cortical Function in Patients with Depressive Illness and Cushing’s Disease. Hormone Research. 23(1). 1–8. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact